Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-week, Open-label, Multi-center Study to Evaluate the Clinical Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic Bladder

NCT01228370 is registered in ClinicalTrials.gov with JW Pharmaceutical as lead sponsor.

NCT NCT01228370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01228370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-week, Open-label, Multi-center Study to Evaluate the Clinical Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic Bladder
Lead sponsor
JW Pharmaceutical
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2011
Completion date
January 31, 2012
Enrollment
95 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

neurogenic bladder, voiding dysfunction